Success of blood test for autism affirmed
One year after researchers published their work on a physiological test for autism, a follow-up study confirms its exceptional success in assessing whether a child is on the autism spectrum. A physiological test that supports a clinician’s diagnostic process has the potential to lower the age at which children are diagnosed, leading to earlier treatment. Results of the study, which uses an algorithm to predict if a child has autism spectrum disorder (ASD) based on metabolites in a blood sample, published online today, appear in the June edition of Bioengineering & Translational Medicine.
“We looked at groups of children with ASD independent from our previous study and had similar success. We are able to predict with 88 percent accuracy whether children have autism,” said Juergen Hahn, lead author, systems biologist, professor, head of the Rensselaer Polytechnic Institute Department of Biomedical Engineering, and member of the Rensselaer Center for Biotechnology and Interdisciplinary Studies (CBIS). “This is extremely promising.”
It is estimated that approximately 1.7 percent of all children are diagnosed with ASD, characterized as “a developmental disability caused by differences in the brain,” according to the Centers for Disease Control and Prevention. Earlier diagnosis is generally acknowledged to lead to better outcomes as children engage in early intervention services, and an ASD diagnosis is possible at 18-24 months of age. However, because diagnosis depends solely on clinical observations, most children are not diagnosed with ASD until after 4 years of age.
Rather than search for a sole indicator of ASD, the approach Hahn developed uses big data techniques to search for patterns in metabolites relevant to two connected cellular pathways (a series of interactions between molecules that control cell function) with suspected links to ASD.
“Juergen’s work in developing a physiological test for autism is an example of how the interdisciplinary life science-engineering interface at Rensselaer brings new perspectives and solutions to improve human health,” said Deepak Vashishth, CBIS director. “This is a great result from the larger emphasis on Alzheimer’s and neurodegenerative diseases at CBIS, where our work joins multiple approaches to develop better diagnostic tools and biomanufacture new therapeutics.”
The initial success in 2017 analyzed data from a group of 149 people, about half of whom had been previously diagnosed with ASD. For each member of the group, Hahn obtained data on 24 metabolites related to the two cellular pathways–the methionine cycle and the transsulfuration pathway. Deliberately omitting data from one individual in the group, Hahn subjected the remaining dataset to advanced analysis techniques and used results to generate a predictive algorithm. The algorithm then made a prediction about the data from the omitted individual. Hahn cross-validated the results, swapping a different individual out of the group and repeating the process for all 149 participants. His method correctly identified 96.1 percent of all typically developing participants and 97.6 percent of the ASD cohort.
The results were impressive and created, said Hahn, a new goal: “Can we replicate this?”
The new study applies Hahn’s approach to an independent dataset. To avoid the lengthy process of gathering new data through clinical trials, Hahn and his team searched for existing datasets that included the metabolites he had analyzed in the original study. The researchers identified appropriate data from three different studies that included a total of 154 children with autism conducted by researchers at the Arkansas Children’s Research Institute. The data included only 22 of the 24 metabolites he used to create the original predictive algorithm, however Hahn determined the available information would be sufficient for the test.
The team used their approach to recreate the predictive algorithm, this time using data of the 22 metabolites from the original group of 149 children. The algorithm was then applied to the new group of 154 children for testing purposes. When the predictive algorithm was applied to each individual, it correctly predicted autism with 88 percent accuracy.
Hahn said the difference between the original accuracy rate and that of the new study can likely be attributed to several factors, the most important being that two of the metabolites were unavailable in the second dataset. Each of the two metabolites had been strong indicators in the previous study.
Overall, the second study validates the original results, and provides insights into several variants on the approach.
“The most meaningful result is the high degree of accuracy we are able to obtain using this approach on data collected years apart from the original dataset,” said Hahn. “This is an approach that we would like to see move forward into clinical trials and ultimately into a commercially available test.”
Learn more: Success of blood test for autism affirmed
The Latest on: Test for autism
via Google News
The Latest on: Test for autism
- Autism Isn’t Colorblind. Here’s Why Diagnosis And Treatment Shouldn’t Be, Either.on October 15, 2019 at 5:20 pm
not only are African American children diagnosed with autism later than their white peers, but they are also referred to specialists less often and are less likely to receive medical tests.
- ‘Medicare For All’ support wanes & Sanger Institute in hot wateron October 15, 2019 at 11:08 am
Ancestry launches consumer genetics tests for health, intensifying rivalry with 23andMe An updated guide to the ... get a new name & suicide attempts among black teens New guidelines for opioid ...
- Carnegie Science Center to host ‘Sensory-Sensitive Day’ for people with autismon October 10, 2019 at 1:42 pm
the science center said. There will be special “touch tables” in the H2Oh! exhibition that will enable visitors to interact with animals, a screening of the movie Autism Goes to College in The Rangos ...
- Airlines offer programs to help people with autism, other developmental disabilitieson October 8, 2019 at 4:38 am
Airlines offer programs to help people with autism, other developmental disabilities originally appeared on ... The tour walks participants through the air travel experience starting with the check-in ...
- Neurobehavioral phenotype of autism spectrum disorder associated with germline heterozygous mutations in PTENon October 8, 2019 at 3:57 am
Parents/guardians also completed a number of inventories designed to measure autism symptoms, sensory processing, behavioral difficulties, and adaptive functioning. The specific cognitive and ...
- Video Game Program Showing Results For Kids With Autism, ADHD, Dyslexiaon October 7, 2019 at 8:52 pm
It’s targeting kids with autism, ADHD, anxiety and dyslexia just to name a few — and it’s adjusted ... is that families come in and they give us stories of improvement,” Lowery said. “They talk about ...
- NJ teen with autism named student council president, a first for the schoolon October 4, 2019 at 3:49 am
For 13-year-old Colin Schaefer, who was diagnosed with autism at a young age and admittedly has trouble expressing himself ... Colin said he wanted the role so he could host some events, but also to ...
- Coastal Bend therapist reacts to President Donald Trump's autism cares billon October 3, 2019 at 8:19 pm
One Coastal Bend program helps kids and adults who are dealing with autism, and now they look at what the additional funding could mean for them. According to the CDC, currently, there are no medical ...
- Boy, Diagnosed With Autism, Epilepsy Triumphs in Karateon October 3, 2019 at 10:36 am
But JP has been diagnosed with autism and epilepsy so finding the perfect sport can be a challenge ... And in early September, his family truly got a taste of how much he's grown. JP had to pass his ...
via Bing News